News on Inhibikase's promising treatments for PAH and Parkinson's Disease, supported by FDA approval and substantial funding.

Azurity Pharmaceuticals has earned FDA approval for Danziten (nilotinib), a new formulation of Novartis’ chronic myeloid ...

Combination of ziftomenib and imatinib shows robust and durable antitumor activity in imatinib-sensitive (1L) and imatinib-resistant (2L/3L) GIST models – – Proof-of-concept study of ziftomenib plus ...

Tier Institutional Healthcare Investors -- -- Advancement of IkT-001Pro into a Late-Stage Clinical Trial Program in Pulmonary ...

What is patent evergreening and what does the Indian patent regime tell us about it? Also, go beyond the nugget to know about ...

If you are looking for an older version of Windows, check out the official list here. Lastly, these keys should only be used for temporary activation. Ultimately, you will have to buy a genuine ...

Get detailed information on Imatinib, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...

Chronic myeloid leukaemia (CML) blockbuster Gleevec has been badly hit by generic competition in the US, revenues falling 30% to $834 million in the period. This decline will continue, with ...

cautious and moderate was the former immigration minister turned rightwing leadership hopeful Robert Jenrick when he entered the Commons that he was nicknamed “Robert Generic”. Yet now 10 ...

Two generic drugmakers, Apotex and Heritage Pharmaceuticals, have agreed to pay a combined $49 million to settle allegations they fixed prices on numerous medicines, the first such agreements ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. The European Commission has fined Teva, the world’s largest generic drugmaker, €462.6mn for hindering ...

By Bulto’s estimate, some 30% to 40% of first-line patients today are being treated with Gleevec or generic imatinib. Novartis expects the first adopters of Scemblix in first-line CML will be ...